Though many expect a hospice M&A rebound in 2024, the scales are tipping in favor of home health companies among buyers. Generally, signs point to heightened buyer activity this year, particularly among private equity as interest rates start to come down. After 2023’s slump, PE firms have been sitting on more than $800 million in […]
Changes in the marketplace have made further acquisitions by VITAS Healthcare more likely. VITAS, a subsidiary of Chemed Corp. (NYSE: CHE), recently announced its first deal in several years, the $85 million purchase of hospice assets from Covenant Health. While the company does not comment on its specific acquisition plans or its pipeline, VITAS may […]
Companies seeking to acquire hospices are keenly attuned to the sellers’ leadership team dynamics when making buying decisions. Amid staffing shortages and heightened regulatory scrutiny, buyers want to work with leaders who have a similar approach to workplace culture, quality and compliance, as well as business operations like marketing and revenue cycle management. The hospice […]
Private equity investors remain bullish on hospice with no signs of slowing down. However, with a number of high-profile transactions completed or in the works during 2020 and 2021, the number of hospices of scale that are likely to come to market is dwindling. During the next few years, PE firms will likely fix their […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
